The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 66.60
Bid: 66.00
Ask: 68.00
Change: -0.80 (-1.19%)
Spread: 2.00 (3.03%)
Open: 67.20
High: 67.40
Low: 66.00
Prev. Close: 67.40
CCEP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update statement on 2023 AGM voting results

24 Nov 2023 14:30

RNS Number : 6433U
Coca-Cola Europacific Partners plc
24 November 2023
 

24 November 2023

Coca-Cola Europacific Partners plc

("the Company")

Update statement on 2023 Annual General Meeting voting results

At the Company's 2023 Annual General Meeting ("AGM") held on 24 May 2023, all resolutions were successfully passed with the requisite majority of votes. However, in respect of resolution 24 ("Rule 9 Waiver Resolution"), we acknowledge that a number of our shareholders did not support the resolution (of votes cast, 78.07% voted in favour)

The Rule 9 Waiver Resolution related to the approval by independent shareholders of a waiver obtained from the Panel on Takeovers and Mergers in respect of an obligation that could arise on Olive Partners, S.A. ("Olive"), or any persons acting in concert with Olive, to make a general offer for all the issued ordinary share capital of the Company following any increase in the percentage of shares held by Olive, or any persons acting in concert with Olive, resulting from the exercise by the Company of the authority to purchase its own shares pursuant to resolutions 28 and 29 (which received approval from 99.78% and 98.42% of those voting respectively). The Board believes that it is in the best interests of shareholders that the Company has the flexibility to return value to shareholders through a possible future buyback programme. If the Rule 9 Waiver Resolution had not been approved, the Company would not be able to effect such buyback programmes as explained in the 2023 Notice of AGM.

Since the AGM, the Company has continued to engage where appropriate with its shareholders to address any concerns they may have. The Company has also communicated with Institutional Shareholder Services on their standing policy to recommend a vote against a Rule 9 waiver which we believe may be influencing investor decisions in this regard.

CONTACTS

Company Secretariat

Clare Wardle

T +44 20 7355 8406

Investor Relations

Sarah Willett

+44 7970 145 218

Media Relations

Shanna Wendt

T +44 7976 595 168

 

ABOUT CCEP

CCEP is one of the leading consumer goods companies in the world. We make, move and sell some the world's most loved brands - serving 600 million consumers and helping 2 million customers across 30 countries grow their business. We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support. The Company is currently listed on Euronext Amsterdam, the NASDAQ Global Select Market, London Stock Exchange and on the Spanish Stock Exchanges, trading under the symbol CCEP. For more information about CCEP, please visit www.cocacolaep.com & follow CCEP on Twitter at @CocaColaEP.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMEADFLASLDFFA
Date   Source Headline
25th Apr 20247:00 amRNSQ1 Trading Update & Interim Dividend Declaration
24th Apr 20241:30 pmRNSDirector/PDMR Shareholding
17th Apr 20241:45 pmRNSDirector/PDMR Shareholding
10th Apr 20249:15 amRNSNotice of AGM
2nd Apr 20242:30 pmRNSTotal Voting Rights
21st Mar 20242:00 pmRNSDirector/PDMR Shareholding
20th Mar 20243:00 pmRNSDirector/PDMR Shareholding
18th Mar 20244:30 pmRNSBlock listing Interim Review
15th Mar 202411:59 amRNSAnnual Financial Report
1st Mar 20242:00 pmRNSTotal Voting Rights
23rd Feb 20247:00 amRNSCompletion of joint acquisition of CCBPI
23rd Feb 20247:00 amRNSPreliminary Unaudited Results Q4 & FY 2023
21st Feb 20245:00 pmRNSDirector/PDMR Shareholding
1st Feb 20242:30 pmRNSTotal Voting Rights
30th Jan 202411:30 amRNSPCC approval received to jointly acquire CCBPI
26th Jan 20244:15 pmRNSDirector/PDMR Shareholding - amendment
25th Jan 202410:30 amRNSDirector/PDMR Shareholding
22nd Jan 20243:15 pmRNSDirector/PDMR Shareholding
17th Jan 202411:30 amRNSDirector/PDMR Shareholding
2nd Jan 20241:30 pmRNSTotal Voting Rights
20th Dec 202311:15 amRNSDirector/PDMR Shareholding
18th Dec 202312:15 pmRNSDirector/PDMR Shareholding
15th Dec 20233:40 pmRNSDirector/PDMR Shareholding
14th Dec 202311:00 amRNSDirectorate Change
1st Dec 20231:45 pmRNSTotal Voting Rights
28th Nov 20234:00 pmRNSDirector/PDMR Shareholding
24th Nov 20232:30 pmRNSUpdate statement on 2023 AGM voting results
21st Nov 20234:30 pmRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSUpdate re acquisition of CCBPI
1st Nov 20231:45 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSQ3 Trading Update & Interim Dividend Declaration
25th Oct 20231:30 pmRNSDirector/PDMR Shareholding
20th Oct 202312:00 pmRNSDirector/PDMR Shareholding
13th Oct 20232:30 pmRNSDirector/PDMR Shareholding
20th Sep 20234:45 pmRNSDirector/PDMR Shareholding
18th Sep 20234:50 pmRNSBlock listing Interim Review
1st Sep 20231:30 pmRNSTotal Voting Rights
22nd Aug 20233:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:01 amRNSResults for the six months ended 30 June 2023
2nd Aug 20237:00 amRNSProposed joint acquisition of CCBPI
1st Aug 20231:05 pmRNSTotal Voting Rights
25th Jul 20234:00 pmRNSDirector/PDMR Shareholding
21st Jul 20232:30 pmRNSDirector/PDMR Shareholding
13th Jul 20233:30 pmRNSDirector/PDMR Shareholding
30th Jun 20234:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20233:00 pmRNSDirector/PDMR Shareholding
8th Jun 202310:50 amRNSDirector/PDMR Shareholding
1st Jun 20232:15 pmRNSTotal Voting Rights
26th May 20234:30 pmRNSDirector/PDMR Shareholding
25th May 202311:30 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.